| Financial Year |
March 31 2023 |
| Monetary Funds |
2,171,987,481.68 |
| Held-for-trading Financial Assets |
119,289,109.60 |
| Notes Receivable |
50,000,000.00 |
| Accounts Receivable |
182,769,018.63 |
| Advances to Suppliers |
367,608,051.63 |
| Other Receivables |
130,253,756.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,151,492,992.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
254,912,940.24 |
| Total Current Assets |
5,428,313,351.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
192,002,092.21 |
| Investment Properties |
162,280,061.21 |
| Fixed Assetes |
3,095,622,563.59 |
| Under-construction Projects |
111,022,930.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
465,520,093.01 |
| R&D expenses |
-- |
| Goodwill |
253,277,962.50 |
| Long-Term Deferred and Prepaid Expenses |
818,677,564.01 |
| Deferred Income Tax Assets |
85,514,853.14 |
| Other Non-Current Assets |
264,868,628.23 |
| Sub-Total of Non-Current Assets |
8,995,637,635.51 |
| Total Assets |
14,423,950,986.58 |
| Short-Term Loans |
506,079,170.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
771,436,335.00 |
| Accounts Payable |
2,159,148,261.64 |
| Accounts Received In Advance |
72,288,861.94 |
| Employee Compensation Payable |
149,246,904.59 |
| Taxes Payable |
95,142,305.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
189,574,556.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
563,616,844.22 |
| Other Current Liabilities |
250,926,309.15 |
| Sub-Total of Current Liabilities |
7,461,834,555.65 |
| Long-term Loans |
-- |
| Bonds Payable |
623,036,021.73 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,311,165.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,365,625,942.36 |
| Total Liabilities |
11,827,460,498.01 |
| Paid-In Capital(Or Share Stock) |
647,336,543.00 |
| Capital Surplus |
1,332,115,985.54 |
| Surplus Reserve |
179,233,009.34 |
| LESS:Treasury Stock |
198,822,462.76 |
| Undistributed Profits |
536,648,440.12 |
| Minority Stockholder's Interest |
6,536,005.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,589,954,483.09 |
| Owner's Equity（Stockholder's Equity） |
2,596,490,488.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,423,950,986.58 |
